Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities. Local targets link to admitted publications; unresolved targets remain external evidence.
The public health impact of parent-reported childhood food allergies in the United States
10.1542/peds.2018-1235 · 2018 · External reference
Food allergy: a practice parameter update—2014
10.1016/j.jaci.2014.05.013 · 2014 · External reference
Peanut allergy: an epidemiologic analysis of a large database
10.1016/j.jpeds.2017.09.026 · 2018 · External reference
Evaluation of the epidemiology of peanut allergy in the United Kingdom
10.1080/1744666x.2020.1693264 · 2019 · External reference
Management of peanut allergy: a focus on novel immunotherapies
2018 · External reference
Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice
10.4049/jimmunol.1003134 · 2011 · External reference
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
10.1016/j.jaci.2016.08.017 · 2017 · External reference
Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial
10.1001/jama.2017.16591 · 2017 · External reference
Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy. The PEPITES randomized clinical trial
10.1001/jama.2019.1113 · 2019 · External reference
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
10.1016/j.jaci.2020.06.028 · 2020 · External reference
Safety of epicutaneous immunotherapy in peanut-allergic children: REALISE randomized clinical trial results
10.1016/j.jaip.2021.11.017 · 2022 · External reference
Unresolved reference
External reference
Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis
10.1159/000245677 · 1997 · External reference
An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial
10.2500/aap.2020.41.200047 · 2020 · External reference
